InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by YK Bioventures Opportunities GP I, LLC. Officer active across 1 company, notably CERO THERAPEUTICS HOLDINGS, INC.. In total, 3 reports have been published. Breakdown: 0 buy · 3 sells. Total volume traded: €540k. Activity tracked since 10 October 2024. The latest transaction was disclosed on 11 December 2024 (Cession). Regulator: SEC (Form 4). All data is openly available.
3 of 3 declarations